Loading...
TrendSpott

TrendSpott

TrendSpott
 
 
ATAI Life Sciences N
1.24
+4.20%
 
Recommendation
ATAI ATAI Life Sciences N
  Login
 
 
Last Price
 
Change
 
1.24
 
+4.20%
 
 

 
Sentiment
 
  Login to display
 
 

1.79

2.57

2.85

4.92

 
 
1m
3m
6m
1y
 

Summary

  Login to display ATAI Life Sciences N (ATAI) recommendation from the last 90 days from financial news and social media.
 

Rewards

Rewards

 Earnings are forecast to grow

 

Risk Analysis

Risk Analysis

 Analysts lowered price target

 
 

Risk Level

 
TrendSpott
 

ATAI Life Sciences N (ATAI) has Extreme Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 
Earnings ×
 

Earnings

3.00
 

TrendSpott

Above analyst estimates

 
 
Rating ×
 

Rating

3.00
 
 
Momentum ×
 

Momentum

2.67
 

TrendSpott

Price value has negative momentum

 
Activity ×
 

Activity

2.63
 
 
Future ×
 

Future

3.67
 

TrendSpott

Earnings are forecast to grow

TrendSpott

Analysts lowered price target

 
 

Analysts Opinion

Analysts opinion is positive and also has improved from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
45%
50%
33%
67%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is unimpressive but have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
45%
50%
Positive
Negative
9 out of 20
events present
10 out of 20
events present
 

 
Events Calendar
Click for more information
 
February
S
M
T
W
T
F
S
March
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Weak Earnings
Today
1.24
+4.20%
 
Strong Earnings
2 Month Ago
1.84
+3.37%
 
Price Target Lowered
3 Month Ago
1.95
-2.99%
 
Upgrade
3 Month Ago
2.01
+3.61%
 
Downgrade
3 Month Ago
1.82
-30.80%
 
Top Headlines

atai life sciences gaap eps of -$0.28 misses by $0.05 revenue of $0.04m misses by $0.07m.

Today

Earnings

atkore gains 10% on upbeat quarterly results increased outlook. (rttnews) - shares of atkore inc. (atkr) are gaining more than 10% wednesday morning after reporting better-than-expected first-quarter results. the company raised its full-year out

Wed Feb 1, 2023

Earnings
Potential

atai life sciences n.v pt lowered to $20 at h.c. wainwright.

Thu Jan 19, 2023

Potential

atai life sciences n.v. (atai) upgraded to buy: heres what you should know. investors might want to bet on atai life sciences n.v. (atai) as it has been recently upgraded to a zacks rank #2 (buy). this rating change essentially reflect

Wed Jan 18, 2023

Momentum
Rating

cathie wood reacts to atais drastic stock plunge after doomed clinical study results. after atai life sciences (nasdaq: ) shared the results of subsidiary perception neuroscience&rsquo.s phase 2 trial of r-ketamine compound for trd the psychedelics biotec

Thu Jan 12, 2023

Momentum

maxim group downgrades atai life sciences n.v to hold.

Fri Jan 6, 2023

Rating

atai life stock slumps 40% as depression drug fails mid-stage study.

Fri Jan 6, 2023

Activity
Activity

atai life sciences phase 2a trial of pcn - 101 fails to meet primary endpoint. (rttnews) - atai life sciences (atai) announced friday that perception neurosciences phase 2a clinical trial of pcn -101 or r-ketamine failed to its primary endpoint

Fri Jan 6, 2023

Activity
Activity

atai life sciences stock declines as phase 1 trial of kur-101 falls short on efficacy. today)released additional clinical datafrom the

Tue Dec 27, 2022

Momentum

atai life sciences kur-101 phase 1 trial shows mixed results on efficacy. today)from theph

Tue Dec 27, 2022

Activity
Earnings

 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss
 

Receive our daily ATAI alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
TrendSpott

TrendSpott

Get the pulse of the market

 
TrendSpott

TrendSpott

ATAI ATAI Life Sciences N

Last Price
1.24
Change
+4.20%
Recommendation
  Login to display
 

Summary

  Login to display ATAI Life Sciences N (ATAI) recommendation from the last 90 days from financial news and social media.

 
 
1.79
2.57
2.85
4.92
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Rewards

Rewards

 Earnings are forecast to grow

Risk Analysis

Risk Analysis

 Analysts lowered price target

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
50%
33%
67%
On Track
On Track
On Track
 
45%
50%
Positive
Negative
9 out of 20
events present
10 out of 20
events present
 

Street Opinion

Street view is unimpressive but have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 
Earnings ×
 

Earnings

3.00
 

TrendSpott

Above analyst estimates

 
 
Rating ×
 

Rating

3.00
 
 
Momentum ×
 

Momentum

2.67
 

TrendSpott

Price value has negative momentum

 
Activity ×
 

Activity

2.63
 
 
Future ×
 

Future

3.67
 

TrendSpott

Earnings are forecast to grow

TrendSpott

Analysts lowered price target

 
 

Analysts Opinion

Analysts opinion is positive and also has improved from the past 3 months

 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Events Calendar
Hover for information
 
February
 
S
M
T
W
T
F
S
 
 
 
March
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Weak Earnings
Today
1.24
+4.20%
 
Strong Earnings
2 Month Ago
1.84
+3.37%
 
Price Target Lowered
3 Month Ago
1.95
-2.99%
 
Upgrade
3 Month Ago
2.01
+3.61%
 
Downgrade
3 Month Ago
1.82
-30.80%
 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss

 

Receive our daily ATAI Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines